Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06802770

Evaluation of Depression and Anxiety Levels of Parents of Children with Spina Bifida

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
Marmara University · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

Studies in the literature have measured the anxiety and depression levels of parents of children with spina bifida. Additionally, it has been reported that parents of children with non-neurogenic lower urinary tract dysfunction, such as nocturnal enuresis and overactive bladder, have increased levels of anxiety and depression. In this study, the investigators aim to evaluate, for the first time, the effect of urinary system symptoms and findings in children with spina bifida on the anxiety and depression levels of their parents.

Detailed description

Between January 2024 and December 2024, the demographic data of patients with spina bifida under follow-up, as well as the results of dimercaptosuccinic acid (DMSA) static renal scintigraphy, urinary ultrasonography (USG), and voiding cystourethrography (VCUG), which indicate upper urinary tract (UUT) damage, were recorded. Symptom scoring was performed on the primary caregiver of the child, and anxiety and depression scores were calculated. The Hospital Anxiety and Depression Scale (HADS) and the Beck Anxiety Inventory were used to assess these symptoms in the parents. The presence of renal scarring, hydronephrosis, or vesicoureteral reflux (VUR) in the DMSA was considered as UUT damage. Patients were divided into subgroups based on demographic data, UUT damage, history of febrile urinary tract infections (UTIs), incontinence, and the presence of motor deficits. These groups were then compared in terms of anxiety and depression scores.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTAnxiety, Depression levelsParents of children with spina bifida will be filled out symptom scores regarding depression and anxiety levels.

Timeline

Start date
2024-01-01
Primary completion
2024-09-01
Completion
2025-01-30
First posted
2025-01-31
Last updated
2025-01-31

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06802770. Inclusion in this directory is not an endorsement.